Pregabalin in fibromyalgia - responder analysis from individual patient data

BACKGROUND: Population mean changes are difficult to use in clinical practice. Responder analysis may be better, but needs validating for level of response and treatment duration. A consensus group has defined what constitutes minimal, moderate, and substantial benefit based on pain intensity and Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Straube, Sebastian, Derry, Sheena, Moore, R Andrew, Paine, Jocelyn, McQuay, Henry J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906437/
https://www.ncbi.nlm.nih.gov/pubmed/20602781
http://dx.doi.org/10.1186/1471-2474-11-150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906437/
https://www.ncbi.nlm.nih.gov/pubmed/20602781
http://dx.doi.org/10.1186/1471-2474-11-150

Ejemplares similares